Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measuring Glutamate and GABA Brain Levels in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Using Magnetic Resonance Spectroscopy (MRS)

NCT04823364 is registered in ClinicalTrials.gov with Weizmann Institute of Science as lead sponsor.

NCT NCT04823364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04823364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measuring Glutamate and GABA Brain Levels in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Using Magnetic Resonance Spectroscopy (MRS)
Lead sponsor
Weizmann Institute of Science
Phase
Not applicable
Overall status
Terminated
Start date
July 11, 2024
Completion date
July 11, 2024
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorder with hyperactivity